DJIA 17,810.06 91.06 0.51%
NASDAQ 4,712.97 11.10 0.24%
S&P 500 2,063.50 10.75 0.52%
market minute promo

34.83 0.55 (1.60%)

Quote as of


company name or ticker

Recent Quotes

XLRN $34.83 1.60%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $34.83
Previous Close $34.28
Daily Range $33.65 - $35.47
52-Week Range $19.77 - $57.89
Market Cap $1.1B
P/E Ratio 24.31
Dividend (Yield) $0.00 (0.0%)
Volume 176,059
Average Daily Volume 234,399
Current FY EPS -$1.25

Sector

Industry

CONTROLADORA VUELA SPON ADR REPR 10 CPOS (XLRN) Description

CONTROLADORA VUELA SPON ADR REPR 10 CPOS Website: http://www.acceleronpharma.com/

News & Commentary Rss Feed

A Quick Look at Celgene Corporation's Drug Development Pipeline

Celgene's drug development pipeline is currently firing on all cylinders; but can it stay that way for long? Find out as we take a closer look at the experimental drugs which matter most to Celgene.

Acceleron Pharma's (XLRN) CEO John Knopf on Q3 2014 Results - Earnings Call Transcript

Acceleron Pharma Is Due For A Market Correction And Is An Attractive Short Candidate During The Comi

Acceleron Pharma Is Due For A Market Correction And Is An Attractive Short Candidate During The Coming Months

Sector Update: Health-care Stocks Higher Pre-Bell

Sector Update: Health Care

Acceleron Initiates Phase 1 Clinical Trial With Innovative Muscle Drug ACE-083

Acceleron Hit Over Competitive Concerns, But Investors Overlook Rest of Pipeline

Will Acceleron (XLRN) Continue to Surge Higher? - Tale of the Tape

Acceleron Pharma (XLRN) Jumps: Stock Rises 12.8% - Tale of the Tape

Acceleron Offers Update on Externally-Sponsored Clinical Trial of Dalantercept Monotherapy in Ovaria

Acceleron Offers Update on Externally-Sponsored Clinical Trial of Dalantercept Monotherapy in Ovarian Cancer

See More XLRN News...